About 92 percent of prescription drugs in the United States reach pharmacies through wholesale distributors. These middlemen buy medications in bulk from manufacturers, store them in massive warehouses, and deliver them to pharmacies on a near-daily basis. The remaining drugs arrive through direct manufacturer shipments or smaller secondary wholesalers, depending on the type of medication and the pharmacy’s size.
The Three Companies That Supply Most Pharmacies
Three wholesale distributors control more than 90 percent of pharmaceutical wholesale distribution in the U.S.: McKesson Corporation, AmerisourceBergen (now Cencora), and Cardinal Health. These companies operate enormous distribution centers across the country, each stocking thousands of different medications. When your local pharmacy fills a prescription, the pill in that bottle almost certainly passed through one of these three companies’ warehouses.
The process works like a grocery supply chain. Manufacturers produce the drugs and sell them to wholesalers, who warehouse the inventory and then sell and distribute it to chain pharmacies, independent pharmacies, hospitals, clinics, nursing homes, and mail-order pharmacies. Most pharmacies place orders electronically, often daily, and receive shipments the next morning. This keeps pharmacies from needing to stockpile large quantities of every medication on their shelves.
Chain pharmacies like CVS and Walgreens have largely moved away from purchasing directly from manufacturers, preferring to buy the majority of their drugs through wholesalers instead. The wholesaler model lets pharmacies consolidate thousands of different products into a single ordering relationship rather than managing contracts with hundreds of individual manufacturers.
Where the Drugs Are Actually Made
Before medications reach a wholesaler’s warehouse, they start as raw ingredients at manufacturing facilities spread across the globe. The active pharmaceutical ingredients in generic drugs, which make up the vast majority of U.S. prescriptions, come primarily from overseas. India is the single largest source, home to about 30 percent of the facilities producing generic active ingredients for the American market. China accounts for roughly 14 percent, followed by Italy at about 11 percent. Only around 8 percent of these facilities are located in the United States itself.
Brand-name drugs and newer biologics tend to have manufacturing concentrated in the U.S. and Europe, where major pharmaceutical companies operate their own production plants. But even these drugs often rely on raw chemical ingredients sourced from India or China before final assembly happens domestically. The global nature of this supply chain is one reason drug shortages can ripple through the system when a single overseas factory has a quality problem or shuts down unexpectedly.
How Wholesalers Shape the Generic Drug Market
Wholesalers do more than just move boxes. For generic drugs, the Big Three essentially act as gatekeepers. Generic manufacturers compete with each other for contracts with these wholesalers, which puts the distributors in the position of being price-setters and market-makers. If a generic manufacturer fails to secure a contract with one of the three major wholesalers, it can be effectively shut out of the U.S. market. This leverage allows wholesalers to negotiate aggressively on generic pricing, which can drive costs down but also squeeze manufacturers thin enough that some exit the market entirely, contributing to shortages.
Specialty Drugs Take a Different Path
Not all medications follow the standard wholesaler route. Specialty drugs, including biologics like certain cancer therapies, autoimmune treatments, and gene therapies, often bypass the traditional distribution chain. Some specialty pharmacies are large enough to acquire these products directly from the manufacturer. This direct relationship exists partly because these medications are expensive (sometimes tens of thousands of dollars per dose) and partly because many require strict temperature control during shipping and storage.
Temperature-sensitive medications like insulin, vaccines, and biologic therapies must travel through what the industry calls a “cold chain.” Federal regulations require that these products ship at specific temperatures, with manual or electronic monitoring equipment documenting proper storage conditions throughout transit. Any break in the cold chain, even a brief temperature excursion during shipping, can compromise the drug’s effectiveness. Manufacturers and distributors use insulated packaging, refrigerated trucks, and continuous temperature loggers to keep these products viable from factory to pharmacy freezer.
Secondary Wholesalers Fill the Gaps
Below the Big Three sits a network of smaller, secondary wholesalers. These companies don’t carry a full line of medications. Instead, they specialize in purchasing discounted products, often from manufacturers running promotional sales or reducing excess inventory, and reselling them throughout the distribution chain. Secondary wholesalers serve an important role for smaller pharmacies and buyers that don’t meet the minimum volume requirements set by the major distributors, or that need smaller package sizes than the Big Three typically offer.
These secondary channels become especially important during drug shortages. When a pharmacy’s primary wholesaler runs out of a medication, pharmacists may turn to secondary distributors, other wholesalers, or even other pharmacies to find available stock. This workaround often comes at higher prices, and the pressure to find supply quickly can create risks. Drug shortages have been linked to purchasing from less established or illegitimate vendors, which is one reason the federal government has tightened supply chain oversight.
Tracking Drugs From Factory to Pharmacy
To prevent counterfeit or diverted drugs from entering the supply chain, the Drug Supply Chain Security Act requires an electronic system for identifying and tracing prescription drugs at the package level as they move from manufacturer to wholesaler to pharmacy. Each package carries a unique serial number, and every entity in the chain must verify that the product is legitimate before passing it along. This track-and-trace system means that by the time a pharmacist scans a bottle to fill your prescription, that specific package has a documented history showing every hand it passed through since leaving the factory floor.
The system isn’t perfect. Secondary market transactions, international sourcing complexities, and the sheer volume of drugs moving through the chain create ongoing challenges. But the combination of federal serialization requirements, wholesaler verification processes, and pharmacy-level checks means the medications reaching licensed U.S. pharmacies have passed through one of the most heavily regulated supply chains in any industry.